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Objective: To examine the epidemiology, primary care burden and treatment of angina in Scotland.
Design: Cross-sectional data from primary care practices participating in the Scottish continuous morbidity
recording scheme between 1 April 2001 and 31 March 2002.
Setting: 55 primary care practices (362 155 patients).
Participants: 9508 patients with angina.
Results: The prevalence of angina in Scotland was 28/1000 in men and 25/1000 in women (p , 0.05)
and increased with age. The prevalence of angina also increased with increasing socioeconomic
deprivation from 18/1000 in the least deprived category to 31/1000 in the most deprived group
(p , 0.001 for trend). The incidence of angina was higher in men (1.8/1000) than in women (1.4/1000)
(p = 0.004) and increased with increasing age and socioeconomic deprivation. Socioeconomically
deprived patients (0.48 contacts/patient among the most deprived) were less likely than affluent patients
(0.58 contacts/patient among the least deprived) to see their general practitioner on an ongoing basis
p = 0.006 for trend). Among men, 52% were prescribed b blockers, 44% calcium channel blockers, 72%
aspirin, 54% statins and 36% angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
The corresponding prescription rates for women were 46% (p , 0.001), 41% (p = 0.02), 69%
(p , 0.001), 45% (p , 0.001) and 30% (p , 0.001). Among patients , 75 years old 52% were
prescribed a b blocker and 58% a statin. The corresponding figures for patients > 75 years were 42%
(p , 0.001) and 31% (p , 0.001).
Conclusions: Angina is a common condition, more so in men than in women. Socioeconomically deprived
patients are more likely to have angina but are less likely to consult their general practitioner. Guideline-
recommended treatments for angina are underused in women and older patients. These suboptimal
practice patterns, which are worst in older women, are of particular concern, as in Scotland more women
(and particularly older women) than men have angina.
A
ngina is an important clinical manifestation of
coronary heart disease. In addition, in patients with
angina the risk of future cardiovascular events can be
prevented with aggressive secondary prevention.1 2 Despite
this, both the contemporary epidemiology and primary care
burden of this condition are remarkably poorly described.
Most existing studies were conducted at least a decade ago.
The majority examined selected cohorts (for example, male
civil servants, with resultant under-representation of women
and the elderly) and used patient questionnaires to diagnose
angina.3–9 One study, carried out in 1984, used nitrate
prescriptions as a proxy for the diagnosis of angina.10
Another study, conducted by the Northern Region Faculty
of the Royal College of General Practitioners, did try to
identify patients with a physician-reported diagnosis of
angina.11 This survey, however, which was conducted in
1979 by 51 general practitioners in the Newcastle region in
England, focussed only on patients aged 30–59 years.
Not only is the contemporary public health burden of
angina poorly described but so is its treatment. With the
emergence of new evidence-based treatments,1 2 publication
of guidelines12 13 and government-directed national health-
improvement programmes in coronary heart disease,14 the
analysis of current prescribing patterns for angina is relevant
and topical.
The Scottish continuous morbidity recording (CMR) in
general practice scheme prospectively collects detailed infor-
mation from several general practices, broadly representative
of the whole Scottish population.15–17
We have used this scheme to give a more contemporary
picture of the epidemiology, primary care burden and
treatment of physician-diagnosed angina than existing
studies would.
METHODS
CMR practice data are compiled by the Primary Care Clinical
Informatics Research Unit based at the University of
Aberdeen. The informatics unit collates both prescribing
and morbidity data from 55 general practices with a total
practice population of 362 155 fully registered patients (7% of
the Scottish population). All people resident in Scotland
(including children) are registered with primary care, which
is free at the point of contact and manages the treatment of
patients once they are discharged from hospital. Secondary
care is usually accessed through a general practitioner based
in a primary care practice.
Trained entry clerks in the general practices participating in
the CMR scheme have recorded the reason for every face to
face doctor–patient contact since March 1996.15–17
Information is collected on the index condition and up to
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10 concomitant medical problems. Each diagnosis is given a
read code18 along with an appropriate modifier of ‘‘first’’,
‘‘recurrent’’ or ‘‘persistent’’ to denote whether the problem is
new, a recurrence of a previous problem or a continuing
problem, respectively. The information and statistics division
administers the CMR project and operates a continuous
quality assurance system for completeness and accuracy of
entry. In 1999–2000 the completeness of capture of contacts
was 91% and the accuracy of read coding was 91%. From the
dataset, we identified all patients registered with the practice
who had a computer record of angina. The practices record
encounters as clinical diagnoses based on a general practice
diagnosis supplemented (especially for serious conditions) by
investigation and diagnostic input from specialist colleagues.
The long-term nature of the database and its clinical focus
ensure that initially uncertain events are confirmed or
refuted over time and the diagnostic codes are amended
appropriately.19 20
For the year 1 April 2001 to 31 March 2002 we identified all
patients who had a record of ever having angina (including
stable and unstable angina). To calculate prevalence the
denominator used was the total registered practice popula-
tion for that year. We also estimated incidence by including
all patients with a read code for angina during the year
ending March 2002 that had a modifier of ‘‘first’’.
General practitioners were asked to record a ‘‘contact’’ for a
condition only if the patient presented with that condition or
if the consultation was relevant to the condition in question
(for example, involving a change of drug for the condition).
Contact rates (total number of consultations or atten-
dances for the year where that condition was indicated as
relevant to the visit) were also calculated. The average
number of contacts for each patient was calculated by
dividing the number of contacts for angina by the number
of patients with angina.
As patients attending the CMR practices are representative
of the Scottish population, the CMR data were used to
estimate prevalence, incidence and contact rates for the
whole Scottish population (5.1 million) on an age- and sex-
specific basis, derived from the 2001 census.
Postcodes of residence were used to assign a Carstairs
deprivation category from 1 (least deprived) to 5 (most
deprived) to each patient.21
Practices routinely record prescribing data on the General
Practice Administration System for Scotland computer
system.19
Statistical analysis
We used x2 tests and x2 tests for trend to compare prevalence,
incidence, contact rates and prescribing data between
different age groups and deprivation categories. By using
the drug of interest as the dependent variable we analysed
multivariate logistic regression to examine the independent
effects of age, sex and deprivation category on prescribing of
different angina drugs. The odds ratios (ORs) were adjusted
for the potential prognostic factors sex, age, deprivation
category, type of general practitioner and co-morbidity
(including prior myocardial infarction, hypertension, heart
failure, stroke, atrial fibrillation and chronic obstructive
airways disease).
RESULTS
Prevalence
The overall prevalence of angina was 28/1000 in men and 25/
1000 in women (1.57 first, 7.70 recurrent and 20.65
persistent). The prevalence of angina was lower in women
than men at all ages (p , 0.05). In men the prevalence was
extremely low in those , 45 (1/1000) increasing to 141/1000
in those > 75 years. In women the prevalence of angina was
108/1000 in those > 75 years. The highest prevalence in both
sexes was in the age range 75–84 years. Although the
prevalence was higher in men than in women, the greater
number of elderly women in the population meant that more
women than men aged > 75 years had angina and that,
overall, almost as many women as men had angina (table 1).
The prevalence of angina increased with increasing socio-
economic deprivation from 18/1000 in the least deprived
group to 31/1000 in the most deprived group—that is,
socioeconomically deprived patients had a 72% higher
prevalence of angina than did affluent patients (p , 0.001
for trend). Similar significant trends were seen in men and
women (table 2).
Extrapolating from the CMR practices to the whole of
Scotland, the estimated number of Scots with angina in 2001
was 133 131 (67 867 men), 68% of whom were > 65 years
old and 32% of whom were > 75 years.
Incidence
The overall incidence of angina for 2001–2 was 1.6/1000. The
incidence was higher in men (1.8/1000) than in women (1.4/
1000). As with prevalence, the incidence of angina greatly
increased with age from 0.1/1000 in men , 45 years to 6.5/
1000 in men aged 65–74 years, and thereafter declined by
50% to 3.1/1000 in men > 85 years. In women the incidence
of angina also increased with age, although it peaked in the
75–84 year age group (5.8/1000) and thereafter declined to
3.2/1000 in those > 85 years. In those > 65 years, the
incidence of angina was 6.1/1000 in men and 4.7/1000 in
women (table 1).
The incidence of angina increased with increasing socio-
economic deprivation from 0.8/1000 in the least deprived
stratum to 2.2/1000 in the most deprived stratum (p , 0.001
for trend)—that is, socioeconomically deprived men were
twice as likely to develop angina and socioeconomically
deprived women were three times more likely to develop
angina compared with affluent men and women (table 2).
The estimated number of Scots presenting with angina for
the first time in the year 2001 was, therefore, 8099 (4378
men), 53% of whom were aged > 65 years and 23% of whom
were > 75 years old.
Contact rates
One-year contact rates for angina were higher in men (15.7/
1000) than in women (12.3/1000). Contact rates increased
with age. These were extremely low in patients , 45 years
old, increased 48-fold in men and 44-fold in women from
, 45 years to 45–64 years and more than doubled again
between 45–64 years and > 65 years. Contact rates per 1000
population were highest in both sexes in the age group 75–84
years (table 1). Men and women with angina had about three
times as many general practitioner contacts a year as those
without angina and, for men and women with angina,
contacts for angina (as opposed to other reasons) accounted
for about one in 20 of all general practitioner contacts made.
On average, patients with angina saw their general
practitioner 0.5 times per annum.
For both men and women, the highest number of contacts
for each patient with angina was in the 45–54 year age band
(0.8 in men and 0.7 in women). After this, in contrast with
prevalence and incidence, the number of contacts declined
with age (table 1). Compared with men, women aged 45–64
years and > 85 years had fewer contacts per patient per year
(p , 0.05).
The number of contacts per patient with angina declined
with increasing socioeconomic deprivation so that patients in
the most deprived group were 33% less likely to see their
general practitioner on an ongoing basis than were affluent
patients (table 2).
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Table 1 Contact rates, incidence and prevalence per 1000 population by sex and age group for all continuous morbidity
recording practices in Scotland for the year ending March 2002
Age group
Practice
population
2001–2
No of patients
with angina
ever Prevalence
No of first
diagnoses of
angina
First ever
incidence
No of contacts
for angina
Contact
rate
No of contacts
per patient
Men
,45 110080 137 1.2 16 0.1 71 0.6 0.52
45–54 25763 566 22.0 63 2.4 463 18.0 0.82
55–64 19929 1313 65.9 98 4.9 859 43.1 0.65
65–74 13740 1713 124.7 89 6.5 784 57.1 0.46
75–84 7256 1061 146.2 44 6.1 540 74.4 0.51
>85 1628 187 114.9 5 3.1 83 51.0 0.44
>65 22624 2961 130.9 138 6.1 1407 62.2 0.48
>75 8884 1248 140.5 49 5.5 623 70.1 0.50
All ages 178396 4977 27.9 315 1.8 2800 15.7 0.56
p value for trend for age ,0.001 ,0.001 ,0.001 ,0.001
Women
,45 106743 69 0.6 7 0.1 48 0.4 0.70
45–54 25185 364 14.5 39 1.5 264 10.5 0.73
55–64 20304 965 47.5 60 3.0 541 26.6 0.56
65–74 15959 1454 91.1 70 4.4 668 41.9 0.46
75–84 11241 1294 115.1 65 5.8 612 54.4 0.47
>85 4327 385 89.0 14 3.2 121 28.0 0.31
>65 31527 3133 99.4 149 4.7 1401 44.4 0.45
>75 15568 1679 107.8 79 5.1 733 47.1 0.44
All ages 183759 4531 24.7 255 1.4 2254 12.3 0.50
p value for trend ,0.001 ,0.001 ,0.001 ,0.001
Both sexes
,45 216823 206 1.0 23 0.1 119 0.5 0.58
45–54 50948 930 18.3 102 2.0 727 14.3 0.78
55–64 40233 2278 56.6 158 3.9 1400 34.8 0.61
65–74 29699 3167 106.6 159 5.4 1452 48.9 0.46
75–84 18497 2355 127.3 109 5.9 1152 62.3 0.49
>85 5955 572 96.1 19 3.2 204 34.3 0.36
>65 54151 6094 112.5 287 5.3 2808 51.9 0.46
>75 24452 2927 119.7 128 5.2 1356 55.5 0.46
All ages 362155 9508 26.3 570 1.6 5054 14.0 0.53
p value for trend ,0.001 ,0.001 ,0.001 ,0.001
Table 2 Incidence, prevalence, and contact rates (per 1000 population), stratified by socioeconomic status for year ending
March 2002
Deprivation
category
Practice
population
No of patients
with angina Prevalence
No of first
diagnoses
of angina
First ever
incidence
No of contacts
for angina Contact rate
No of contacts
per patient
Men
1 (least) 39277 768 19.6 36 0.9 491 12.5 0.64
2 34298 898 26.2 57 1.7 448 13.1 0.50
3 54240 1622 29.9 102 1.9 884 16.3 0.55
4 34221 1163 34.0 89 2.6 718 21.0 0.62
5 (most) 15612 511 32.7 31 2.0 255 16.3 0.50
Odds ratio between category 1 and 5 1.70 2.17 1.31 0.56
95% CI 1.51 to 1.90 1.34 to 3.51 1.13 to 1.53 0.45 to 0.71
p for trend ,0.001 ,0.001 ,0.001 0.142
Women
1 (least) 40488 677 16.7 30 0.7 343 8.5 0.51
2 36070 815 22.6 42 1.2 429 11.9 0.53
3 55976 1501 26.8 86 1.5 759 13.6 0.51
4 34614 1067 30.8 60 1.7 511 14.8 0.48
5 (most) 15908 458 28.8 37 2.3 207 13.0 0.45
Odds ratio between category 1 and 5 1.74 3.14 1.54 0.80
95% CI 1.55 to 1.97 1.94 to 5.09 1.30 to 1.84 0.63 to 1.02
p for trend ,0.001 ,0.001 ,0.001 0.015
Both sexes
1 (least) 79765 1445 18.1 66 0.8 834 10.5 0.58
2 70368 1713 24.3 99 1.4 877 12.5 0.51
3 110216 3123 28.3 188 1.7 1643 14.9 0.53
4 68835 2230 32.4 149 2.2 1229 17.9 0.55
5 (most) 31520 969 30.7 68 2.2 462 14.7 0.48
Odds ratio between category 1 and 5 1.72 2.61 1.41 0.67
95% CI 1.58 to 1.87 1.86 to 3.66 1.26 to 1.58 0.57 to 0.79
p for trend ,0.001 ,0.001 ,0.001 0.006
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Concomitant medical conditions
Table 3 shows the top 10 concomitant medical problems in
patients consulting with angina. In both sexes, upper
respiratory tract infection was the most common reason for
general practitioner consultation and the most common
concomitant diagnostic coding in patients with angina (39%
of men and 49% of women). Hypertension was the second
most frequently coded, reported for 34% of men and 42% of
women. After adjustment for age, women were more likely
than men to have concomitant respiratory problems (upper
respiratory tract infection, p , 0.001; chest infection,
p , 0.001; chronic obstructive airways disease, p = 0.035),
hypertension (p , 0.001), backache (p , 0.001), dyspepsia
(p , 0.001) and depression (p , 0.001) and men were more
likely than women to have diabetes (p = 0.003), pain in a
limb (p , 0.001) and myocardial infarction (p , 0.001).
Pharmacological treatment
Table 4 shows the drugs prescribed for patients with angina
stratified by age. A b blocker was prescribed for 49%, a
calcium channel blocker for 43%, a nitrate for 56%, an
angiotensin converting enzyme (ACE) inhibitor, an angio-
tensin receptor blocker or both for 33%, a statin for 50% and
an antiplatelet agent for 73%.
There were significant sex differences in prescribing. Of
men, 52% were prescribed a b blocker, 44% a calcium channel
blocker, 72% aspirin, 54% a statin, 36% an ACE inhibitor or
an angiotensin receptor blocker and 20% optimal evidence-
based treatment (that is, an antiplatelet drug plus a statin
plus an ACE inhibitor). The corresponding prescription rates
for women were 46% (p , 0.001), 41% (p = 0.02), 69%
(p , 0.001), 45% (p , 0.001), 30% (p , 0.001) and 14%
(p , 0.001). The prescription rates were lower if a history of
myocardial infarction was excluded, with 17.3% of men and
12.0% of women receiving optimal evidence-based treatment,
compared with 35.8% (36.5% men and 34.5% women) with a
previous myocardial infarction. On multivariate analysis after
adjustment for age, deprivation, general practitioner practice
and co-morbidity, compared with men, women were less
likely to be prescribed a b blocker (OR 0.86, 95% confidence
interval (CI) 0.78 to 0.93), a calcium channel blocker (OR
0.85, 95% CI 0.78 to 0.93), an antiplatelet agent (OR 0.82,
95% CI 0.74 to 0.90), a statin (OR 0.83, 95% CI 0.76 to 0.91),
an ACE inhibitor, angiotensin receptor blocker or both (OR
0.69, 95% CI 0.63 to 0.76) and optimal evidence-based
treatment (OR 0.68, 95% CI 0.60 to 0.76) (table 5).
There were also significant age-related differences in
prescribing (table 4). A b blocker was prescribed for 52% of
patients , 75 years compared with 42% of those > 75 years
old (p , 0.001). Similarly, younger patients were more likely
to be prescribed a statin (58% , 75 years compared with 31%
> 75 years, p , 0.001) and optimal evidence-based treat-
ment (19% , 75 years compared with 12% > 75 years,
p , 0.001). Older patients were more likely to be prescribed a
nitrate (61%) and warfarin (8%) than were younger patients
(54%, p , 0.001 and 5%, p , 0.001, respectively).
On multivariate analysis, men > 75 years old were less
likely to be prescribed a b blocker (OR 0.67, 95% CI 0.59 to
0.78), a statin (OR 0.30, 95% CI 0.26 to 0.34), an ACE
inhibitor, angiotensin receptor blocker or both (OR 0.76, 95%
CI 0.65 to 0.89) and optimal evidence-based treatment (OR
0.51, 95% CI 0.42 to 0.62) and were more likely to be
prescribed a nitrate (OR 1.42, 95% CI 1.23 to 1.62). Women
> 75 years old were also less likely to be prescribed a b
blocker (OR 0.71, 95% CI 0.62 to 0.81), a statin (OR 0.33, 95%
CI 0.29 to 0.38) or an ACE inhibitor, angiotensin receptor
blocker or both (OR 0.78, 95% CI 0.66 to 0.91) and were also
more likely to be prescribed a nitrate (OR 1.24, 95% CI 1.08 to
1.41).
With increasing socioeconomic deprivation, patients were
less likely to be prescribed a b blocker (p for trend = 0.018)
and more likely to be prescribed a nitrate (p for
trend = 0.006) and an ACE inhibitor (p for trend = 0.02).
On multivariate analysis, patients in the most deprived
stratum were 25% more likely to be prescribed a nitrate or a
calcium channel blocker, 51% more likely to be prescribed an
ACE inhibitor angiotensin receptor blocker or both, and 81%
more likely to be prescribed warfarin than were patients in
the least deprived stratum. There were no differences,
however, in prescribing of statins (OR 0.92, 95% CI 0.77 to
1.10) or antiplatelet drugs (OR 1.08, 95% CI 0.89 to 1.32)
according to socioeconomic deprivation. Socioeconomically
deprived patients with angina were 64% more likely to be
prescribed optimal evidence-based treatments.
DISCUSSION
In Scotland, in 2001–2, the prevalence of angina was 2.6%.
Both prevalence and incidence were higher in men than in
women, and increased steeply with age and with increasing
socioeconomic deprivation. Women and older patients were
less likely to receive evidence-based treatment.
Our estimates of prevalence (and incidence) were based on
general practitioner-reported diagnoses. This approach has
strengths and weaknesses compared with the more com-
monly used alternative of administration of a questionnaire
(usually the Rose one).22 There have been concerns that the
questionnaire approach may overestimate the prevalence of
angina, especially in women. The positive predictive value of
the Rose angina questionnaire in comparison with exercise
thallium testing has been reported to be 67%23 and as low as
Table 3 Proportion of patients with angina seen in the year ending March 2002 with a
specified concomitant condition or illness
Condition/illness
CMR angina patients Total CMR practice population*
Men
(n = 4977)
Women
(n = 4531)
Men
(n = 178396)
Women
(n = 183759)
Upper respiratory tract infection 1915 (38.5%) 2224 (49.1%) 57620 (32.3%) 76901 (41.9%)
Hypertension 1685 (33.9%) 1904 (42.0%) 14232 (8.0%) 19283 (10.5%)
Pain in limb 1330 (26.7%) 1564 (34.5%) 18323 (10.3%) 25670 (14.0%)
Backache 1279 (25.7%) 1570 (34.7%) 31071 (16.9%) 23254 (13.0%)
Chest infection 1291 (25.9%) 1458 (32.2%) 10945 (6.1%) 14809 (8.1%)
Dyspepsia 1142 (22.9%) 1243 (27.4%) 13270 (7.4%) 15600 (8.5%)
Depressive disorder 474 (9.5%) 816 (18.0%) 8096 (4.5%) 18437 (10.0%)
Chronic obstructive airways disease 609 (12.2%) 629 (13.9%) 3949 (2.2%) 4461 (2.4%)
Diabetes 661 (13.3%) 501 (11.1%) 4538 (2.5%) 3936 (2.1%)
Myocardial infarction 647 (13.0%) 357 (7.9%) 1470 (0.8%) 745 (0.4%)
*p,0.01 for difference in proportion of continuous morbidity recording (CMR) angina patients and total CMR
practice population.
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25% in women.24 Conversely, reliance on a medical diagnosis
may underestimate prevalence, as patients with unrecognised
angina or very mild symptoms may not attend (or be
correctly identified by) their general practitioner. In the
Whitehall II study 70% of those who developed angina did
not have a diagnosis at the time of their initial report.25
We found an overall prevalence of angina of 2.8% in men
(7.1% in patients > 45 years old and 13.1% in those > 65
years) and 2.5% in women (5.8% in patients > 45 years and
9.9% in those > 65 years). Our findings, therefore, give a
somewhat higher rate than the 7.1% prevalence in men . 65
years old in the Nottingham nitrate study carried out during
1984–8510 and a slightly lower rate than the 8.3% prevalence
in patients . 45 years reported in a more recent study of 48
general practices in the Wakefield region of northern
England, which used a similar investigative approach to that
of the Nottingham study.26 Another study, based on data
from the 1998 Health Survey for England, gave a self-
reported prevalence of angina (recall of a doctor’s diagnosis)
of about 3% in men and women > 16 years old.27
The prevalence we found is also comparable with that
reported from some studies with a questionnaire-based
approach,3 7 6 28 but lower than in others of this type.8 29 5
Why our prevalence is lower than in those latter studies is not
entirely certain. Apart from the methodological difference
discussed above, many of the other surveys were conducted
in selected cohorts and up to 25 years earlier than the current
study (that is, since when the incidence of coronary disease is
thought to have been declining). Even the more recent
questionnaire-based studies, however, have reported a higher
prevalence of angina than that found in our study. Another
explanation is the inclusion of possible as well as definite
Rose angina.29
Prior studies commonly reported a higher prevalence of
angina in women than in men, a finding inconsistent with
the epidemiology of acute coronary syndromes and coronary
deaths and the protection from coronary heart disease
enjoyed by premenopausal women.5 9 28 30–33 This anomaly
has been attributed to an increased tendency for women to
score positive for angina on the Rose questionnaire. We did
not find a female preponderance of angina; indeed, we saw
the opposite, as have other studies based on a physician’s
diagnosis or prescription of angina drugs.10 26 34
As in all prior studies, we also found that the prevalence of
angina increased with age, although hardly any have
explored the full age range.35 Most patients (59% of men
and 69% of women) were aged > 65 years and a substantial
minority were > 75 years old (25% of men and 37% of
women). This is in striking contrast with the typical age
range of patients enrolled in clinical trials36 or undergoing
coronary revascularisation (only about 6% of patients in
Scotland undergoing revascularisation in 2002–3 were older
than 75 years). Also of note, although the overall prevalence
of angina was lower in women than in men, the prevalence in
older women approached those of men and, because of the
greater number of older women than men in the population
generally, more women than men aged > 75 years had
angina.
In contrast with prevalence studies, there are very few prior
surveys of the incidence of angina and most of these date
from the 1970s.37–39 In one more recent study, comparing
coronary heart disease rates between France and Northern
Ireland, the incidence of angina in French men aged 50–59
years was 2.6/1000 compared with 5.4/1000 in Irish men; in
Scotland it was 3.5/1000 in men aged 45–64 years.40 In
contrast, an earlier study from Southampton, England
reported an incidence of only 0.8/1000 in men and women
aged 31–70 years (compared with 2.9/1000 in Scotland in
patients aged 45–64 years).41 Although the standardised
mortality ratio for coronary heart disease is higher in
Northern Ireland and Scotland than in southern England,
the Southampton incidence seems unusually low (and lower
than in France) and probably reflects the methods used in
that study. Patient identification required referral to a special
chest pain clinic, patients with any prior evidence of coronary
heart disease were excluded and, where possible, patients
underwent exercise electrocardiography.
Consultation rates, reflecting the primary care burden of
angina, were relatively low with less than one visit per
patient per year. Women had a lower number of contacts per
patient per year than men, at all ages. The reason for this is
not clear, especially as women, in general, have more
contacts with primary care physicians than men do (about
twice as many)—that is, women have more opportunities for
angina to be recorded at a contact. There is some evidence
that women may seek help for angina less often than men.42
It is also possible that primary care physicians may record
angina (as one of a number of problems) less often in women
than in men (the general practitioner decided which medical
problems were recorded as clinically important during
contacts); there is evidence that physicians regard chest pain
in women as less clinically significant than in men.43
The co-morbidities recorded for our patients with angina
are not unexpected. Respiratory problems are the most
common reason for a primary care consultation, and
dyspepsia and depression are also known to be common
reasons for consultation. The higher proportion of co-
morbidities in the angina group than in the general
population may be related to their older age and more
frequent general practitioner contact. Hypertension, diabetes
and myocardial infarction reflect the known relationships
between these problems and angina. The prevalence of these
co-morbidities is similar to that reported from other primary
care studies and large angina trials.44 45 Interestingly, we
found that patients with angina were more likely to have
depression than the general population. An association
between a history of depression and a heavier angina burden
has been shown previously.46
Although patients with angina can be expected to have
more co-morbidity than those without, the difference may
have been exaggerated because patients with angina have
more frequent contact with their general practitioner and
therefore more opportunity for co-morbidities to be recorded.
Our study gives one of the most representative and up to
date descriptions of the treatment of patients with angina.
The use of evidence-based secondary preventive treatments is
higher than in most prior studies27 47 and similar to that
found in the Euro Heart Survey of Stable Angina, which
focused on newly diagnosed angina in patients presenting to
a cardiologist.48 Although treatment with antiplatelet drugs
was recorded for only 73% of our patients, others may be
taking over-the-counter, self-purchased aspirin. Only about
half of the patients were prescribed a statin, however, and
less than a third an ACE inhibitor, although the most recent
evidence supports the use of these drugs by all patients who
can tolerate them.1 2 49 Drugs that modify lipids or reduce the
risk of thrombosis substantially reduce the risk of myocardial
infarction and death.1 50 ACE inhibitors can also significantly
improve outcome in patients with stable coronary artery
disease.49 We found that female sex and older age were
associated with underuse of one or more guideline-recom-
mended treatments (particularly b blockers and statins),
even after multivariate adjustment. This reflects patterns
previously described in the use of coronary revascularisation
procedures, in the management of acute coronary syndromes
and, recently, in the treatment of coronary heart disease
(myocardial infarction and angina combined) in primary
care.27 44 47 We do not know of prior data on angina alone (as
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opposed to coronary heart disease); this is an important
distinction, as patients with prior myocardial infarction are
more likely to be prescribed these treatments than are those
with angina.27 47 51 Although it can be argued that the
underprescribing in our study may, in part, reflect the lower
number of consultations per patient per year among women
and the elderly, this is not supported by examination of the
pattern of prescribing among socioeconomically deprived
patients, who appeared to be less undertreated despite lower
contact rates (see below).
We found a quite strong relationship between socio-
economic deprivation and the prevalence and incidence of
angina, in keeping with previous reports of higher rates of
several different manifestations of coronary heart disease in
these disadvantaged patients. Socioeconomically deprived
patients with angina had a lower rate of contacts per patient
per year. Despite this lower contact rate, deprived patients
were less obviously undertreated than were women or older
patients. Indeed, deprived patients were more likely to be
treated with ACE inhibitors, perhaps reflecting greater
contact with secondary care, where these drugs are more
likely to be prescribed. Another recent UK study has also
found that, after multivariable adjustment, social deprivation
was not associated with underuse of either medical treat-
ments or cardiac procedures.52
A limitation to our study is that only patients who attend a
physician for angina are included and it is known that there
is a significant proportion of people with undiagnosed angina
in the community.25
In summary, we have described the substantial burden of
angina in primary care. It is a common condition affecting 3%
of the population, with the prevalence rising to 12% among
patients aged > 75 years. Although the incidence and
prevalence of angina increase with increasing socioeconomic
deprivation, deprived patients with angina have less frequent
follow up with their general practitioner. Although, overall,
the use of evidence-based treatments is better than in prior
studies, there is scope for further improvement in prescribing.
The overall suboptimal use of treatments may, in part, reflect
the pronounced age and sex discrepancies in prescribing of
evidence-based treatments, with the elderly and women
receiving less guideline-recommended treatment. These
discrepancies warrant further investigation.
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Angiographic documented dobutamine induced coronary spasm successfully treated by stenting
A
66-year-old diabetic and hypertensive patient receiving
chronic calcium channel antagonist (CCA) treatment
presented with unstable angina caused by single vessel
coronary artery disease (CAD), which was successfully
treated by direct stenting of the proximal left anterior
descending artery (LAD).
Two days after hospital discharge the patient had typical
angina with two episodes of syncope. At the emergency
department an inferior myocardial infarction was evident
upon ECG (upper panel). Coronary angiography showed
patency of the LAD stent and no significant lesion on the
right coronary artery (RCA) (lower panel A). In order to
assess the possibility of RCA vasospasm we performed an
intravenous dobutamine stress test which resulted in a
significant mid RCA spasm (lower panel B). The spasm
persisted despite stopping the dobutamine perfusion and
instituting intracoronary nitrate injection. In view of this life
threatening RCA spasm refractory to intracoronary nitrates
and oral CCA, we decided to treat the culprit lesion by stent
implantation (lower panels C and D) with favourable early
and late outcomes.
Dobutamine induced coronary spasm is often suspected
after stress echocardiography but has only occasionally been
reported at angiography. Our case suggests that in the
presence of underlying CAD, variant angina may be a
challenging problem. Medical treatment (nitrates or CCA)
should be attempted in such cases, but if symptoms persist
coronary stenting seems to be the rational option. Spasm may
occur everywhere in the vessel, therefore in patients
suspected of having medical refractory variant angina,
provocation tests should always be performed before stent-
ing, in order to identify and treat the culprit spasmodic
segment only.
R F Bonvini
T Hendiri
U Sigwart
ulrich.sigwart@hcuge.ch
1054 Murphy, Simpson, MacIntyre, et al
www.heartjnl.com
 on 5 November 2009 heart.bmj.comDownloaded from 
